Literature DB >> 17587687

Cell surface-bound plasminogen regulates hepatocyte proliferation through a uPA-dependent mechanism.

Nobuaki Okumura1, Taiichiro Seki, Toyohiko Ariga.   

Abstract

Plasminogen and plasminogen activators play important roles in liver regeneration. Previously, we found that plasminogen potentiates hepatocyte proliferation in the primary culture of rat hepatocytes. Here, we examined how exogenous plasminogen affects the downstream events leading to cell proliferation. The addition of plasminogen to hepatocytes increased urokinase-type plasminogen activator (uPA) activity, but did not affect matrix metalloproteinase (MMP)-9 or MMP-2 activities. To increase uPA activity, plasminogen was required to bind the hepatocyte surface through the lysine-binding site of plasminogen molecule, but neither uPA mRNA nor uPA receptor (uPAR) mRNA was affected by the exogenous plasminogen. In addition, treatment of hepatocytes with an uPA inhibitor, p-aminobenzamidine, inhibited the plasminogen-induced and even EGF-induced hepatocyte proliferation. These results suggest that plasminogen-related control of hepatocyte proliferation is exerted topically by producing a hyperfibrinolytic state on the cellular surface involving the activation of uPA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17587687     DOI: 10.1271/bbb.70126

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  2 in total

1.  A novel function of thrombin-activatable fibrinolysis inhibitor during rat liver regeneration and in growth-promoted hepatocytes in primary culture.

Authors:  Nobuaki Okumura; Tomohiko Koh; Yuichi Hasebe; Taiichiro Seki; Toyohiko Ariga
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

2.  Silymarin Accelerates Liver Regeneration after Partial Hepatectomy.

Authors:  Jia-Ping Wu; Chin-Chuan Tsai; Yu-Lan Yeh; Yueh-Min Lin; Chien-Chung Lin; Cecilia Hsuan Day; Chia-Yao Shen; V Vijaya Padma; Lung-Fa Pan; Chih-Yang Huang
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-03       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.